# Thrombocytopenia Investigation & Referral - Category: chronic - Review status: reviewed (every claim checked against a document named on this page) - Sources: BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus. · BSH Guideline for the Investigation and Management of ITP 2020 - Verified date: 2026-08 ## Verified against - BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus. - BSH Guideline for the Investigation and Management of ITP 2020 - Thrombocytopenia - disease-level clinical article (thrombocytopenia-referral-clinical.txt) ## Treatment metadata - Prednisolone — 5 mg — oral.solid - Referral & safety-netting (no drug therapy) ## Complete treatment card ```text THROMBOCYTOPENIA INVESTIGATION & REFERRAL Sources: BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus. · BSH Guideline for the Investigation and Management of ITP 2020 Review status: REVIEWED against BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus., BSH Guideline for the Investigation and Management of ITP 2020, Thrombocytopenia - disease-level clinical article (thrombocytopenia-referral-clinical.txt) (2026-08) IS IT THIS? - reference only, to read alongside your own examination SYMPTOMS - what the patient reports (4) - Patients are usually symptom-free above 50,000/uL platelets, while spontaneous bleeding is common below 20,000/uL [bleeding] - A bleeding history should cover petechiae, bleeding episodes, gum bleeding, and nosebleeds [bleeding · gum bleeding · nosebleed · petechiae] - Mouth purpura and visible blood in the urine deserve special attention as possible warnings of severe ITP-related bleeding [bleeding · blood in the urine · purpura · rash] - In pregnancy, headache, vision changes, abdominal pain, or a flu-like illness may suggest preeclampsia or HELLP syndrome [abdominal pain · headache] SIGNS - what you find (4) - Typical bleeding signs are petechiae, purpura that is not raised, and bruising [bleeding · bruising · petechiae · purpura · rash] - Dry purpura is confined to the skin, while wet purpura involves the mucous membranes and signals higher bleeding risk [bleeding · purpura · rash] - An enlarged liver or spleen points toward lymphoma, chronic liver disease, or another blood disorder [hepatomegaly] - Enlarged lymph nodes can point to infection, autoimmune disease, lymphoma, or another malignancy [lymphadenopathy] TESTS (8) - Initial work-up includes a CBC, peripheral smear, HIV and hepatitis C testing, and a repeat CBC to rule out a lab error - Anemia accompanying thrombocytopenia raises suspicion for infection, DIC, sepsis, thrombotic microangiopathy, or an autoimmune disorder such as Felty syndrome - A high white count alongside low platelets suggests infection, malignancy, or chronic inflammation, while pancytopenia points to a myelodysplastic syndrome - Suspected autoimmune disease warrants antinuclear and antiphospholipid antibody testing - A bone marrow biopsy is needed when the cause stays unclear or a blood cancer is suspected - Normal or high megakaryocyte counts on marrow biopsy suggest increased platelet destruction, while reduced megakaryocytes with other low cell lines suggest aplastic anemia - In SLE, a severe drop or absence of marrow megakaryocytes can result from antibodies against the thrombopoietin receptor - Megaloblastic marrow changes point to B12, folate, or copper deficiency, while dysplastic cell features point to myelodysplastic syndrome IF NOT THIS - what else fits (3) - Pseudothrombocytopenia is a lab artifact from in-vitro platelet clumping caused by EDTA- dependent agglutinins, poor specimen anticoagulation, or glycoprotein IIb/IIIa inhibitors - Automated cell counters can mistake unusually large platelets for white blood cells, giving a falsely low platelet count - A functional platelet defect from uremia or liver disease can be mistaken for true thrombocytopenia despite a normal platelet count Source StatPearls "Thrombocytopenia" - disease-level clinical article Status traced to the source above 1. PREDNISOLONE [1st line] Adult 1 mg/kg once daily in the morning for 2-4 weeks, then taper under specialist haematology guidance x 2-4 weeks initial course Peds 1-2 mg/kg/day [child max 60 mg] (1-2 mg/kg once daily (max 60 mg) for 14 days under pediatric haematologist guidance) 3kg -> 3-6 mg/day 4kg -> 4-8 mg/day 5kg -> 5-10 mg/day 6kg -> 6-12 mg/day 7kg -> 7-14 mg/day 8kg -> 8-16 mg/day 9kg -> 9-18 mg/day 10kg -> 10-20 mg/day 11kg -> 11-22 mg/day 12kg -> 12-24 mg/day 13kg -> 13-26 mg/day 14kg -> 14-28 mg/day 15kg -> 15-30 mg/day 16kg -> 16-32 mg/day 17kg -> 17-34 mg/day 18kg -> 18-36 mg/day 19kg -> 19-38 mg/day 20kg -> 20-40 mg/day 21kg -> 21-42 mg/day 22kg -> 22-44 mg/day 23kg -> 23-46 mg/day 24kg -> 24-48 mg/day 25kg -> 25-50 mg/day 26kg -> 26-52 mg/day 27kg -> 27-54 mg/day 28kg -> 28-56 mg/day 29kg -> 29-58 mg/day 30kg -> 30-60 mg/day 31kg -> 31-60 mg/day (upper capped) 32kg -> 32-60 mg/day (upper capped) 33kg -> 33-60 mg/day (upper capped) 34kg -> 34-60 mg/day (upper capped) 35kg -> 35-60 mg/day (upper capped) 36kg -> 36-60 mg/day (upper capped) 37kg -> 37-60 mg/day (upper capped) 38kg -> 38-60 mg/day (upper capped) 39kg -> 39-60 mg/day (upper capped) 40kg -> 40-60 mg/day (upper capped) 41kg -> 41-60 mg/day (upper capped) 42kg -> 42-60 mg/day (upper capped) 43kg -> 43-60 mg/day (upper capped) 44kg -> 44-60 mg/day (upper capped) 45kg -> 45-60 mg/day (upper capped) 46kg -> 46-60 mg/day (upper capped) 47kg -> 47-60 mg/day (upper capped) 48kg -> 48-60 mg/day (upper capped) 49kg -> 49-60 mg/day (upper capped) 50kg -> 50-60 mg/day (upper capped) Source BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus. Why First-line initial therapy for acute symptomatic ITP with platelet count <30 x 10^9/L or mucosal bleeding Caution URGENT HAEMATOLOGY REFERRAL IS MANDATORY for unexplained low platelets (<100 x 10^9/L). Perform blood film immediately to exclude pseudothrombocytopenia (EDTA clumping), acute leukaemia, microangiopathic haemolytic anaemia (TTP/HUS), or aplastic anaemia. AVOID NSAIDs, Aspirin, and IM injections. Emergency admission is needed if there is active severe bleeding or platelets <10 x 10^9/L. Egypt HOSTACORTIN H 5MG 30 TAB. SANOFI 12.00 EGP (0.40/unit) PREDNISOLONE 5 MG 20 TABS. ARAB DRUG COM... 24.00 EGP (1.20/unit) PREDILONE 5MG 10 TAB. (25 STRIPS PACK) KAHIRA 250.00 EGP (25.00/unit) EPICOPRED 5 MG 30 ORODISPERSIBLE TABS. EIPICO 69.00 EGP PREDNISOLONE-EVA 5 MG 30 ORODISPERSIBLE TABS. EVA PHARMA 79.50 EGP DISPRELONE-OD 5 MG 30 ORODISPERSABLE TABS. ANDALOUS PHARMA 84.00 EGP SOLUPRED ORO 5 MG 30 ORODISPERSIBLE TABS. SANOFI WINTHROP > SANOFI 84.00 EGP ACETASEE 1% EYE DROPS (SUSP.) 5 ML RAMEDA 7.50 EGP -> ? strength differs, ? different route - not oral solid PREDNIS 5MG/5ML SYRUP 100 ML PHAROPHARMA 9.50 EGP -> ? strength differs, ? different route - not oral solid 2. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY) [1st line] Adult Source Thrombocytopenia - disease-level clinical article (thrombocytopenia-referral- clinical.txt) Why Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen. Caution RED FLAG - Immediate (not routine) hematology consultation is required for life- threatening causes: TTP, HUS, HIT, aplastic anemia, leukemia, and other bone-marrow- failure conditions. Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy. ``` --- Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement. [Privacy policy](/privacy)